Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Recruiting
Observational Study
Healthy Donors
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- Checkmab S.r.l. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* blood donors
* age of 18 years or more
* able to sign informed consent
Exclusion Criteria:
* age below 18 years
* Positive for HIV, HCV, HBV
* not suitable for blood donation
* not able to understand or sign informed consent
Contacts